The 10-day moving average for ATR crossed bullishly above the 50-day moving average on October 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 67%.
The Momentum Indicator moved above the 0 level on October 15, 2026. You may want to consider a long position or call options on ATR as a result. In 48 of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 59%.
The Moving Average Convergence Divergence (MACD) for ATR just turned positive on October 14, 2026. Looking at past instances where ATR's MACD turned positive, the stock continued to rise in 37 of 57 cases over the following month. The odds of a continued upward trend are 65%.
ATR moved above its 50-day moving average on October 22, 2026 date and that indicates a change from a downward trend to an upward trend.
The 50-day moving average for ATR moved above the 200-day moving average on November 10, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +10.12% 3-day Advance, the price is estimated to grow further. Considering data from situations where ATR advanced for three days, in 179 of 335 cases, the price rose further within the following month. The odds of a continued upward trend are 53%.
The Aroon Indicator entered an Uptrend today. In 120 of 222 cases where ATR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 54%.
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 8 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 17 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ATR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 51%.
ATR broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron PE Growth Rating for this company is 13 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. ATR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 59 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 71 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ATR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.
The Tickeron Valuation Rating of 73 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.447) is normal, around the industry mean (4.964). P/E Ratio (25.446) is within average values for comparable stocks, (40.591). Projected Growth (PEG Ratio) (2.595) is also within normal values, averaging (4.143). Dividend Yield (0.013) settles around the average of (0.005) among similar stocks. P/S Ratio (2.072) is also within normal values, averaging (56.876).
IQV moved above its 50-day moving average on November 06, 2026 date and that indicates a change from a downward trend to an upward trend. In 21 of 28 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 75%.
The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on IQV as a result. In 49 of 77 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 64%.
The Moving Average Convergence Divergence (MACD) for IQV just turned positive on November 10, 2026. Looking at past instances where IQV's MACD turned positive, the stock continued to rise in 26 of 41 cases over the following month. The odds of a continued upward trend are 63%.
Following a +5.27% 3-day Advance, the price is estimated to grow further. Considering data from situations where IQV advanced for three days, in 186 of 301 cases, the price rose further within the following month. The odds of a continued upward trend are 62%.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IQV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 64%.
IQV broke above its upper Bollinger Band on October 21, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is 9 (best 1 - 100 worst), indicating outstanding price growth. IQV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 27 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 43 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 77 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.251) is normal, around the industry mean (67.298). P/E Ratio (33.477) is within average values for comparable stocks, (4.239). Projected Growth (PEG Ratio) (0.985) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (2.693) is also within normal values, averaging (9.775).
The Tickeron Profit vs. Risk Rating rating for this company is 83 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IQV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock better than average.
ATR | IQV | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 39 | 32 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 73 Overvalued | 77 Overvalued | |
PROFIT vs RISK RATING 1..100 | 71 | 83 | |
SMR RATING 1..100 | 59 | 43 | |
PRICE GROWTH RATING 1..100 | 39 | 9 | |
P/E GROWTH RATING 1..100 | 13 | 27 | |
SEASONALITY SCORE 1..100 | 11 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ATR's Valuation (73) in the Containers Or Packaging industry is in the same range as IQV (77) in the Servicestothe Health Industry industry. This means that ATR’s stock grew similarly to IQV’s over the last 12 months.
ATR's Profit vs Risk Rating (71) in the Containers Or Packaging industry is in the same range as IQV (83) in the Servicestothe Health Industry industry. This means that ATR’s stock grew similarly to IQV’s over the last 12 months.
IQV's SMR Rating (43) in the Servicestothe Health Industry industry is in the same range as ATR (59) in the Containers Or Packaging industry. This means that IQV’s stock grew similarly to ATR’s over the last 12 months.
IQV's Price Growth Rating (9) in the Servicestothe Health Industry industry is in the same range as ATR (39) in the Containers Or Packaging industry. This means that IQV’s stock grew similarly to ATR’s over the last 12 months.
ATR's P/E Growth Rating (13) in the Containers Or Packaging industry is in the same range as IQV (27) in the Servicestothe Health Industry industry. This means that ATR’s stock grew similarly to IQV’s over the last 12 months.
| ATR | IQV | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 33% | N/A |
| Stochastic ODDS (%) | 1 day ago 41% | 1 day ago 73% |
| Momentum ODDS (%) | 1 day ago 59% | 1 day ago 64% |
| MACD ODDS (%) | 1 day ago 65% | 1 day ago 63% |
| TrendWeek ODDS (%) | 1 day ago 52% | 1 day ago 63% |
| TrendMonth ODDS (%) | 1 day ago 52% | 1 day ago 67% |
| Advances ODDS (%) | 10 days ago 53% | 3 days ago 62% |
| Declines ODDS (%) | 6 days ago 51% | 10 days ago 64% |
| BollingerBands ODDS (%) | 1 day ago 49% | 1 day ago 58% |
| Aroon ODDS (%) | 1 day ago 54% | N/A |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ATR’s FA Score shows that 1 FA rating(s) are green while IQV’s FA Score has 2 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ATR’s TA Score shows that 7 TA indicator(s) are bullish while IQV’s TA Score has 4 bullish TA indicator(s).
ATR (@Pharmaceuticals: Other) experienced а +1.27% price change this week, while IQV (@Medical Specialties) price change was +4.78% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +4.44%. For the same industry, the average monthly price growth was +4.11%, and the average quarterly price growth was +16.86%.
The average weekly price growth across all stocks in the @Medical Specialties industry was -4.40%. For the same industry, the average monthly price growth was -7.16%, and the average quarterly price growth was +34.99%.
ATR is expected to report earnings on Feb 18, 2027.
IQV is expected to report earnings on Feb 11, 2027.
Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
@Medical Specialties (-4.40% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
A.I.dvisor indicates that over the last year, ATR has been loosely correlated with SYK. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if ATR jumps, then SYK could also see price increases.
A.I.dvisor indicates that over the last year, IQV has been closely correlated with CRL. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if IQV jumps, then CRL could also see price increases.
| Ticker / NAME | Correlation To IQV | 1D Price Change % | ||
|---|---|---|---|---|
| IQV | 100% | -1.32% | ||
| CRL - IQV | 71% Closely correlated | -2.13% | ||
| TMO - IQV | 67% Closely correlated | -0.48% | ||
| RVTY - IQV | 59% Loosely correlated | -1.01% | ||
| A - IQV | 58% Loosely correlated | -1.27% | ||
| ICLR - IQV | 54% Loosely correlated | -1.43% | ||
More | ||||